Adalimumab induced interstitial lung disease

Tumor necrosis factor inhibitors have been implicated in many pulmonary complications. Before starting these class of drugs latent infection as tuberculosis and preexisting lung disease should be excluded. These agents have been linked to pulmonary nodules, pneumonitis, fibrosis, autoimmune reaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Aqsa, Anum, Sharma, Dikshya, Chalhoub, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005541/
https://www.ncbi.nlm.nih.gov/pubmed/32055438
http://dx.doi.org/10.1016/j.rmcr.2020.101012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005541/
https://www.ncbi.nlm.nih.gov/pubmed/32055438
http://dx.doi.org/10.1016/j.rmcr.2020.101012

Ejemplares similares